Skip to main navigation Skip to search Skip to main content

A Phase 2, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MEDI-563, A Humanized Anti-Interleukin-5 Receptor Alpha Monoclonal Antibody, on Asthma Control in Adults Following Acute Exacerbations

Project: Research

Project Details

StatusFinished
Effective start/end date04/6/09 → 01/27/11

Funding

  • MedImmune Incorporated: $2,500.00